The Thought Leadership & Innovation Foundation released a whitepaper on the CMS Medicare Advantage Final Rule, highlighting its impact on value-based care in orthotics and prosthetics (O&P). Alongside this, they launched Limb Outcomes Voice (LOV), a pilot platform enabling patients with limb loss to report outcomes and access personalized insights. These initiatives aim to integrate patient data and outcomes into healthcare reimbursement and policy, emphasizing the shift toward measurable clinical results and patient experience in O&P. The foundation calls for collaboration among providers and stakeholders to improve data transparency and define future value metrics in healthcare for limb loss and preservation.
Analysts have raised their price targets for Cheniere Energy, signaling confidence in the company's future growth. Argus increased its target to $330, suggesting a 20.33% upside from the current price of around $274. TD Cowen also raised its target t...
KeyBanc and DA Davidson upgraded Duolingo's stock rating, citing positive sentiment and raising price targets to $137.11 and $160 respectively. This upgrade lifted Duolingo shares by 4.3% in pre-market trading to $135.71. Despite this optimism, most ...
ReNew Energy Global exceeded analyst expectations in Q1 FY2027 by reporting EPS of $0.17 versus $0.12 estimated and revenue of $506.4 million, surpassing the $459.86 million forecast. The company expanded its renewable energy portfolio to about 20.5 ...
Jack Henry & Associates is expected to report Q2 earnings with an EPS of $1.47 and revenue of $631.6 million. Analysts note the company has a strong record of beating earnings estimates, with an average surprise of nearly 20% in recent quarters. Fina...
Argenx reported successful Phase 3 clinical trial results for its drug VYVGART Hytrulo, targeting autoimmune myositis, especially benefiting patients with IMNM who lack approved therapies. The trial met its primary endpoint with statistically signifi...
